A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia

Project: Research project

Project Details

StatusActive
Effective start/end date3/12/20 → 8/31/50

Funding

  • BioMarin Pharmaceutical Inc.